- Home
- ANVS vs YSXT Comparison
ANVS vs YSXT Comparison
Compare ANVS & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | YSXT |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 58.6M |
| IPO Year | 2020 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ANVS | YSXT |
|---|---|---|
| Price | $3.85 | $1.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 866.0K |
| Earning Date | 11-12-2025 | 07-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $71,452,736.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.30 |
| Revenue Growth | N/A | ★ 22.04 |
| 52 Week Low | $1.11 | $1.25 |
| 52 Week High | $6.37 | $9.96 |
Technical Indicators
Market Signals| Indicator | ANVS | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 37.95 |
| Support Level | $4.12 | $1.25 |
| Resistance Level | $4.64 | $1.80 |
| Average True Range (ATR) | 0.51 | 0.32 |
| MACD | -0.14 | -0.06 |
| Stochastic Oscillator | 10.56 | 35.83 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.